← Back to catalogue

PathVysion HER-2 DNA Probe Kit

FDA PMA

Class III (US FDA PMA)

PMA P980024

by Abbott Molecular, Inc.

Identity

Trade Name
PATHVYSION HER-2 DNA PROBE KIT FDA PMA
Generic Name
SYSTEM, TEST, HER-2/NEU, NUCLEIC ACID OR SERUM FDA PMA

Identifiers

PMA Number
P980024 FDA PMA
FDA Product Code
MVD FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Pathology FDA PMA
FDA Decision
APPR Approved FDA PMA

The PathVysion HER-2 DNA Probe Kit is a system test designed to detect amplification of the HER-2/neu gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded human breast cancer tissue specimens. It is intended as an adjunct to existing clinical and pathologic information for prognostic use in stage II, node-positive breast cancer patients.

The kit is supplied for use in pathology laboratories and is indicated to aid in predicting disease-free and overall survival in patients with stage II, node-positive breast cancer treated with adjuvant CAF chemotherapy. It has received FDA PMA authorization (P980024) and is classified as a Class III device under product code MVD.

Frequently asked questions

What type of specimen is required for the PathVysion HER-2 DNA Probe Kit?

The kit requires formalin-fixed paraffin-embedded human breast cancer tissue specimens, as specified in the device's approval statement for FISH-based detection of HER-2/neu gene amplification.

Is the PathVysion HER-2 DNA Probe Kit intended for use in all breast cancer patients?

No, the kit is specifically indicated as an adjunct to clinical and pathologic information for prognostic use in stage II, node-positive breast cancer patients, not for all breast cancer cases.

What chemotherapy regimen is associated with the prognostic use of the PathVysion HER-2 DNA Probe Kit?

The kit is intended to aid in predicting disease-free and overall survival in patients with stage II, node-positive breast cancer treated with adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) chemotherapy.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P980024 24 fields · synced Sep 18, 2026